Navigation Links
Cervical Cancer Vaccine Well Tolerated
Date:12/4/2008

Reactions such as hives called 'idiosyncratic,' study finds

THURSDAY, Dec. 4 (HealthDay News) -- Reactions to the vaccine designed to protect against cervical cancer are rare, and young women can tolerate subsequent doses.

That's the assessment of Australian researchers who analyzed data after more than 380,000 doses of the Gardasil vaccine were given to girls in secondary schools beginning in April 2007.

Gardasil protects against four types of human papillomavirus (HPV) that increase the risk of cervical cancer. Some ingredients of the vaccine, such as aluminum salts and yeasts, have previously been associated with hypersensitivity reactions.

The Australian researchers identified 35 schoolgirls with suspected hypersensitivity reactions, including hives, generalized rash, swelling of subcutaneous tissues (angioedema), and severe allergic reaction (anaphylaxis).

Twenty-five of the girls agreed to be referred to pediatric allergy centers for further evaluation. This included a detailed account of their reactions, such as previous doses of the vaccine, time and severity of reaction, and previous clinical history. Skin tests of HPV vaccines were conducted, and vaccine challenges were administered intramuscularly. The girls were followed-up by telephone one week after the subsequent dose, and any adverse events were noted, the researchers said.

Nineteen girls had skin testing of the Gardasil vaccine, and all were negative. Seventeen of 18 girls later "challenged" with the vaccine tolerated further doses. One girl reported a limited case of hives four hours after receiving the vaccine. Only three of the 25 evaluated girls had probable hypersensitivity to the vaccine, and the researchers concluded that true hypersensitivity is rare.

They noted that suspected hypersensitivity reactions such as hives are often "idiosyncratic" and don't increase the risk of adverse reactions in subsequent vaccinations. Girls with suspected hypersensitivity to the vaccine should be evaluated before receiving further doses, said the researchers, who called for more research into the mechanisms of hypersensitivity to the vaccine.

The study was published online Dec. 3 in the BMJ.

More information

The U.S. National Cancer Institute has more about HPV vaccines.



-- Robert Preidt



SOURCE: British Medical Journal, news release, Dec. 3, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Cervical cancer screening: Too many are left unprotected
2. Couples more likely to divorce if spouse develops cervical or testicular cancer
3. Gene-Based Screen Spots Cervical Cancer Earlier
4. Transcutaneous cervical esophageal ultrasound can not substitute for 24-h pH monitoring or manometry
5. Advaxis, Inc. phase I/II results of lovaxin C in cervical cancer study released
6. Study: HPV test beats Pap in detecting cervical cancer
7. NEJM Report Finds HPV Test More Effective Than Pap in Determining Cervical Cancer Risk
8. Pa. Funding for Cervical Cancer Prevention Services Ends
9. Precancerous Lesions Raise Cervical Cancer Risk
10. American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening
11. Study Finds New Version of QIAGENs HPV Test for Developing Countries Could Reduce Risk of Cervical Cancer by More than Half When Combined With Appropriate Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Cambridge, MA, ... steady since 2009, according to a Workers Compensation Research Institute (WCRI) study, a ... the North Carolina System: CompScope™ Benchmarks, 17th Edition looks at indemnity and ...
(Date:5/23/2017)... ... May 23, 2017 , ... The National Council on ... to announce the organization’s Certified Strength Coach credential has earned accreditation from the ... program validates the competency of qualified candidates for jobs in the Strength and ...
(Date:5/23/2017)... ... 2017 , ... By all indications, and due to months of wet weather, ... diligence, asking homeowners to scout for any open water sources that can be emptied ... buzz of mosquitos is the buzz associated with potential infections stemming from their itchy ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... chat as a standard feature on its secure clinical communication platform. The platform ... to video depending on the type and urgency of a situation. , ...
(Date:5/23/2017)... CA (PRWEB) , ... May 23, 2017 , ... New ... gums and chronic bad breath, can now receive laser gum disease treatments from the ... Douglas Campbell and David Landau are raising awareness of the importance of receiving qualified ...
Breaking Medicine News(10 mins):
(Date:5/23/2017)... 2017  Leaf Healthcare, recognized for developing one ... pressure ulcer prevention, will unveil its comprehensive mobility ... Care Nurses, National Teaching Institute and Critical Care ... Leaf Patient Monitoring System is the first mobility ... The system seamlessly tracks patient movement throughout the ...
(Date:5/18/2017)... 18, 2017  Two Bayer U.S. Pharmaceutical leaders received ... its recent 28 th Woman of the ... showcases HBA,s longstanding mission of furthering the advancement and ... Cindy Powell-Steffen , senior director of brand ... and Libby Howe , a regional business manager ...
(Date:5/15/2017)... Inc., a privately-held CNS pharmaceutical company based in ... disease (PD), has enrolled the first patient in the RASMET ... study involving patients with PD and taking place at 12 ... period. The first stage is open label and involves single ... Denver , Boca Raton ...
Breaking Medicine Technology: